Shanghai - based genomic information company WuXi NextCode has raised $ 200 m in a series C funding round led by the Ireland Strategic Investment Fund . The latest cash round will enable the firm to grow its newly acquired business in Dublin , Genomics Medicine Ireland , which was acquired as part of a $ 200 m investment in Irish precision medicine . The focus will be placed on the company 's disease biomarker identification initiative , as well as its population genomics study , which will sequence the genomes of 400,000 Irish people . The round was led by the Ireland Strategic Investment Fund (ISIF), which contributed $70 million, and included existing shareholders Temasek, Yunfeng Capital, and Sequoia Capital. The Chinese firm intends to collate the world 's leading genome data - set in Ireland as a vehicle for drug - discovery .
Shanghai - based genomic information company WuXi NextCode has raised $ 200 m in a series C funding round led by the Ireland Strategic Investment Fund . The latest cash round will enable the firm to grow its newly acquired business in Dublin , Genomics Medicine Ireland , which was acquired as part of a $ 200 m investment in Irish precision medicine . The focus will be placed on the company 's disease biomarker identification initiative , as well as its population genomics study , which will sequence the genomes of 400,000 Irish people . The Chinese firm intends to collate the world 's leading genome data - set in Ireland as a vehicle for drug - discovery .